You searched for - Page 204 of 412 - Institute for Bioengineering of Catalonia

12th IBEC Symposium: Bioengineering for Active Ageing

The IBEC annual symposium brings together high-profile international experts for an open forum for interdisciplinary discussions and networking. This year the symposium is dedicated to Bioengineering for Active Ageing, … Read more

12th IBEC Symposium: Bioengineering for Active Ageing

Laboratory Technician at the Biomaterials for regenerative therapies Research Group

Application Deadline: 20/06/2019
Ref: TEC-EE

The Biomaterials for regenerative therapies group at the Institute for Bioengineering of Catalonia (IBEC) is searching for a Technician position to work in in vivo models for biomaterial development. Research in the Biomaterials for Regenerative Therapies group is devoted to the development and knowledge transfer to industry and innovative biomaterials and scaffolds for tissue regeneration.

Binucleated cells could be the key in heart regeneration

A research team led by the IBEC, in collaboration with the CMR [B], discovers a mechanism that generates binucleated cells.This mechanism has been identified during the regeneration of the heart of the zebrafish, and could be associated with the extraordinary regenerative power of this animal.

After an acute heart lesion, such as a myocardial infarction, the human heart is unable to regenerate. The adult cardiac cells cannot grow and divide to replace the damaged ones, and the lesion becomes irreversible. But this does not happen in all animals. A freshwater fish native to Southeast Asia, known as a zebrafish, can completely regenerate its heart even after 20% ventricular amputation.

10 medical advances that will revolutionize the future

Nuria Montserrat and Pere Roca-Cusachs interviewed in the article “10 scientific advances that will revolutionize the future” of the newspaper Ara, talking about 3D tissue printing and mechanobiology.

IBEC’S Nano Robots presented at the European Research Council

Research Professor Samuel Sánchez presented last March 3rd in Brussels the new generation of NanoBots and BioBots developed in his research group at Institute of Bioengineering of Catalonia (IBEC) in Barcelona.

The presentation took place during the European Research Council (ERC) Seminars. The audience was composed of scientific personnel of ERC, as well as a general audience from the European Commission.
With the title “Nanobots to 3D BioBots as future tools in robotics and medicine” Professor Sánchez presented during his seminar, fundamental aspects of catalytically powered nanoparticles -also called nanobots-, their applications in environmental remediation and also in future smart nanomedicine.

Postdoc Position at Biomimetic systems for cell engineering

Application Deadline: 15/07/2019
Ref: PD-EM

The Biomimetic systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Postdoctoral Researcher to work in the frame of a european project.

Research Assistant at Biomimetic systems for cell engineering

Application Deadline: 19/06/2019
Ref: RA-EM

The Biomimetic systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Research Assistant to work in the frame of a European project.

PhD Position at Biomimetic systems for cell engineering

Application Deadline: 31/06/2019
Ref: PhD-EM

The Biomimetic systems for cell engineering group at the Institute for Bioengineering of Catalonia (IBEC) is looking for Pre-doctoral Researcher to develop his/her PhD thesis project on the development of new models of engineered tissues.

Postdoctoral researcher at the Translational Fibroblast Mechanobiology Research Group

Application Deadline: 17/06/2019
Ref: PD-JA

The Translational Pulmonary Fibroblast Mechanobiology Group led by Dr. Jordi Alcaraz at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Postdoctoral researcher to study the aberrant fibroblast phenotypes of lung cancer patients, with the ultimate goal to identify new therapeutic targets and/or biomarkers..